27 Apr Oranix Solution (oral rinse) (Benzydamine HCl 22,5 mg/15 ml; Chlorhexidine gluconate 18,0 mg/15 ml)
| Company name & Address: |
registration number |
Batch number(s) |
Expiry date |
Pack size |
First distributed |
Re-call Classification |
Re-call Date |
| iNova Pharmaceuticals (Pty) Ltd
15E Riley Road, Bedfordview, 2007 South Africa |
34/16.4/0391 |
126189 |
11/2023 |
200 ml |
13.12.2021 |
Class III Type C |
28 January 2022 |
Reason for recall
This product is being recalled due to a complaint relating to quality defect: The assay of the active pharmaceutical ingredient, chlorhexidine gluconate, is below approved specification and the efficacy of this product cannot be guaranteed, (Assay limit of Chlorhexidine Gluconate ut of specification).
Advice to HCPs/Distributors/Public:
Immediate batch tracing, quarantine of stock from all distributors & their clients, immediate notification to recall the batches
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.